Cherry Abacus Marijuana Strain

4.7
4.7
19 votes| 1 review
Write a Review Favorite Strain

Indica Dominant Hybrid Strain Indica Dominant Hybrid 60% Indica / 40% Sativa

THC: 1%, CBD: 20%

Cherry Abacus, also known as “Cherry Abacus CBD” or “Cherry Abacus Hemp,” is a slightly indica dominant hybrid strain (60% indica/40% sativa) created thro9ugh crossing the delicious Original Cherry X Abacus strains. Beloved for its amazing flavor and super high CBD level, Cherry Abacus is a great choice for any patient who's after a high level of potency with their medicine. Because it has an insanely high CBD level and low THC level, the effects of Cherry Abacus are pretty mild in nature, serving to calm and soothe rather than leave you feeling stoned. You'll feel a light mental boost with the onset of this high as your mind is filled with a happy sense of calm that won't affect your energy level. A soothing body high accompanies this happy lift, helping you feeling totally at ease and free of any aches or pains. Thanks to these effects and its low 0-1% THC level and super high 18-20% average CBD level, Cherry Abacus is often chosen to treat conditions such as chronic pain, inflammation, cramps or muscle spasms, chronic fatigue and arthritis. This bud has a sweet and fruity cherry berry flavor with and earthy herbal aroma to go with it. Cherry Abacus buds have dense oversized diamond-shaped forest green nugs with thin reddish-orange hairs and a coating of frosty, golden-amber crystal trichomes.
Roll over the stars, then click to rate.
Why write a strain review?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.Post Review

I cant believe how wonderful this strain makes me feel. Creative, calm, at peace, pain reliever. It's like a beautiful high without the fog.

Consumption Method: Vape Dry FlowersEffects I Feel: Euphoria, Mellow, UpliftingHelp Me With: Anxiety, Chronic Pain, InflammationAromas: Blueberry, Cherry, Grassy, TeaFlavors: Cherry, Grassy, Rose, Tea
Hippielady   - Nov. 8, 2023, 8:40 p.m.|
Trending Articles
Loading...